This article was originally published by The 19th.
There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...
An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...
A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
All nine patients treated at Dana-Farber Cancer Institute ... generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine. The vaccines were administered ...
All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...
In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.